CIK 0000034956
- Non-accelerated filer
- Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262593535
- Phone
- +1 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 4 Open-market buy Chief Medical Officer bought 5,000 shares at an average $9.12 ($45,622)
- 4 Open-market buy CEO bought 2,605 shares at an average $7.68 ($20,000)
- 4/A Open-market buy Director bought 1,993 shares at an average $7.50 ($14,945)
- 4 Open-market buy Interim CFO bought 8,000 shares at an average $7.27 ($58,164)
- 4 Open-market buy Director bought 1,993 shares at an average $7.50 ($14,945)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 11 · 206 filings